怀孕不良结果与未来动脉样硬化的发展之间是否存在关系?
Anastasia V Poznyak1, Victoria A Khotina2, Elena B Zhigmitova2
1Institute for Atherosclerosis Research, Osennyaya 4-1-207, 121609 Moscow, Russia.
Biomedicines
|September 28, 2023
概括
妊娠期糖尿病和高血压疾病等不良妊娠结果与晚期心血管疾病有关. 了解这些联系可以揭示关键的性别特异性动脉样硬化风险因素.
科学领域:
- 生殖内分泌学和心血管医学.
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 早期识别心血管疾病风险因素对于有效管理和预防动脉样硬化至关重要.
- 负面的妊娠结果影响超过30%的女性,并且越来越多地被认为是未来心血管风险的潜在指标.
研究的目的:
- 审查妊娠不良结果与动脉样硬化心血管疾病发展之间的关联.
- 探索将妊娠糖尿病,妊娠高血压障碍,流产和死产等疾病与女性心血管健康联系在一起的潜在机制.
- 识别因妊娠并发症引起的心血管疾病的潜在性别特异性风险因素.
主要方法:
- 系统审查最近的科学文献.
- 来自研究特定妊娠障碍与心血管系统影响之间的病理生理联系的研究数据的分析.
- 专注于孕期糖尿病,妊娠高血压障碍,流产和死胎的潜在机制.
主要成果:
- 有证据表明,不良妊娠结果与产后心血管疾病风险增加之间存在显著的相关性.
- 特定的妊娠并发症具有共同的潜在机制,这些机制有助于动脉样硬化的发展.
- 这些情况可能是女性心血管风险的早期指标.
结论:
- 负面的怀孕结果是评估女性长期心血管健康的关键窗口.
- 了解妊娠并发症和动脉样硬化之间的共享途径可以改善心血管风险分层和有针对性的干预措施.
- 需要进一步研究来自怀孕的性别特异性心血管风险因素.
相关概念视频
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Psychoneuroimmunology: Cardiovascular Disease
46
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
46
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12


